There were experiments illustrating oncogenic role of TP53I3 in papillary thyroid cancer through activating the PI3K/AKT/PTEN pathway (Xu et al., 2015) and in non-small cell lung cancer by promoting mitotic progression (Li et al., 2017). This evidence concerns the gene TP53I3 and non-small cell lung carcinoma.